Posts tagged ACHN


What Analysts Are Saying About Biotech Stocks Achillion Pharmaceuticals, Inc. And ACADIA Pharmaceuticals Inc.

Achillion Pharmaceuticals, Inc. Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) shares are rising about 25% in Wednesday’s trading …

Achillion Pharmaceuticals, Inc. (ACHN) Shares Skyrocket Following 2Q:17 Results and Clinical Update

Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) reported financial results for the three and six months ended June …

Here’s Why Maxim Slashed Price Target on Achillion Pharmaceuticals, Inc. (ACHN) Today

Maxim analyst Jason Kolbert slashes his price target on shares of Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) to …

Achillion Pharmaceuticals (ACHN) Shares Might’ve Just Hit A Bottom; Chardan Upgrades

In a research report released Friday, Chardan analyst Madhu Kumar upgraded shares of Achillion Pharmaceuticals, …

Analysts Speculate on Two Falling Biotech Stocks: Achillion Pharmaceuticals, Inc. (ACHN) and bluebird bio Inc (BLUE)

News from Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) and bluebird bio Inc (NASDAQ:BLUE) have sent biotech investors …

Achillion Pharmaceuticals, Inc. (ACHN) Provides 3Q:16 Update; Shares Fall 19%

Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) reported financial results for the three months ended September 30, 2016. For …

Company Update (NASDAQ:ACHN): Achillion Pharmaceuticals, Inc. Announces Updated Interim Results From Janssen’s Phase 2 Trial in Genotype 1 Treatment-Naïve HCV

Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) announced that updated interim results were presented today in an ePoster describing …

Company Update (NASDAQ:ACHN): Achillion Pharmaceuticals, Inc. Presents Novel Research on Factor D Inhibition at the XXVIth International Complement Workshop

Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) announced the presentation of two posters which detailed novel preclinical research into …